Applied Therapeutics Files 8-K on Shareholder Votes
| Field | Detail |
|---|---|
| Company | Applied Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, shareholder-vote
Related Tickers: APLT
TL;DR
APLT filed an 8-K for shareholder votes. Nothing major revealed yet.
AI Summary
Applied Therapeutics, Inc. filed an 8-K on June 12, 2025, reporting on matters submitted to a vote of security holders as of June 9, 2025. The filing details the company's corporate structure, including its incorporation in Delaware and principal executive offices in New York. No specific voting outcomes or proposals were detailed in the provided excerpt.
Why It Matters
This filing indicates that Applied Therapeutics, Inc. is engaging in corporate governance activities, specifically related to votes by its security holders, which is a standard but important disclosure for public companies.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain information that inherently increases risk for the company or its investors.
Key Numbers
- 001-38898 — Commission File Number (Identifies the company's SEC filing history.)
- 81-3405262 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Applied Therapeutics, Inc. (company) — Registrant
- June 09, 2025 (date) — Date of earliest event reported
- June 12, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- New York (location) — Address of Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Applied Therapeutics, Inc. security holders?
The provided excerpt does not detail the specific matters submitted to a vote. It only states that the 8-K filing is for 'Submission of Matters to a Vote of Security Holders'.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 09, 2025.
What is the Commission File Number for Applied Therapeutics, Inc.?
The Commission File Number for Applied Therapeutics, Inc. is 001-38898.
Where are the principal executive offices of Applied Therapeutics, Inc. located?
The principal executive offices of Applied Therapeutics, Inc. are located at 545 Fifth Avenue, Suite 1400, New York, New York, 10017.
What is the Standard Industrial Classification (SIC) code for Applied Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Applied Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Applied Therapeutics, Inc..